secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001628280-22-016201
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cumberland Pharmaceuticals announces retirement of EVP Leo Pavliv
-----------------------------------------------------------------

- Leo Pavliv retired as EVP, Chief Development & Operations Officer effective May 31, 2022.
- Pavliv entered into a consulting agreement to remain as Operations Advisor to the company.
- His regulatory, product development and manufacturing duties have been assigned to other executives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/0001628280-22-016201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000162828022016201/cpix-20220603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-016201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer